| 1. |
Cunha, G. R., Hayward, S. W., Dahiya, R., and Foster, B. A. (1996) Smooth muscle-epithelial interactions in normal and neoplastic
prostatic development. Acta Anatomica
155, 63–72.
|
| |
| 2. |
Hayward, S. W., Cunha, G. R., and Dahiya, R. (1996) Normal development and carcinogenesis of the prostate: A unifying hypothesis.
Ann. NY Acad. Sci.
784, 50–62.
|
| |
| 3. |
Hayward, S. W., Rosen, M. A., and Cunha, G. R. (1997) Stromal-epithelial interactions in normal and neoplastic prostate. Br. J. Urol.
79(Suppl. 2), 18–26.
|
| |
| 4. |
Cooke, D. B., Quarmby, V. E., Mickey, D. D., Isaacs, J. T., and French, F. S. (1988) Oncogene expression in prostate cancer:
Dunning R3327 rat dorsal prostatic adenocarcinoma system. Prostate
13, 263–272.
|
| |
| 5. |
Thompson, T. C., Kadmon, D., Timme, T. L., Merz, V. W., Egawa, S., Krebs, T., et al. (1991) Experimental oncogene induced
prostate cancer, in Prostate Cancer: Cell and Molecular Mechanisms in Diagnosis and Treatment (Isaacs, J. T., ed.), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, pp. 55–72.
|
| |
| 6. |
Peehl, D. M. (1993) Oncogenes in prostate cancer. Cancer
71, 1159–1164.
|
| |
| 7. |
Wang, Y. Z. and Wong, Y. C. (1997) Oncogenes and tumor suppressor genes in prostate cancer: a review. Urol. Oncol.
3, 41–46.
|
| |
| 8. |
Sarkar, F. H., Sakr, W., Li, Y. W., Macoska, J., Ball, D. E., and Crissman, J. D. (1992) Analysis of retinoblastoma (Rb) gene
deletion in human prostatic carcinomas. Prostate
21, 145–152.
|
| |
| 9. |
Isaacs, W. B., Bova, G. S., Morton, R. A., Bussemakers, M. J., Brooks, J. D., and Ewing, C. M. (1994) Genetic alterations
in prostate cancer. Cold Spring Harb. Symp. Quant. Biol.
59, 653–659.
|
| |
| 10. |
Fearon, E. R. and Vogelstein, B. (1990) A genetic model for colorectal tumorigenesis. Cell
61, 759–767.
|
| |
| 11. |
Martin, K. J. and Sager, R. (1998) Expression genetics in cancer research, prognosis, and therapy. Adv. Exp. Med. Biol.
451, 1–7.
|
| |
| 12. |
Bookstein, R., Rio, P., Madreperla, S. A., Hong, F., Allred, C., Grizzle, W. E., and Lee, W. H. (1990) Promoter deletion and
loss of retinoblastoma gene expression in human prostate carcinoma. Proc. Natl. Acad. Sci. USA
87, 7762–7766.
|
| |
| 13. |
MacGrogan, D. and Bookstein, R. (1997) Tumour suppressor genes in prostate cancer. Semin. Cancer Biol.
8, 11–19.
|
| |
| 14. |
Yeh, S., Miyamoto, H., Nishimura, K., Kang, H., Ludlow, J., Hsiao, P., et al. (1998) Retinoblastoma, a tumor suppressor, is
a coactivator for the androgen receptor in human prostate cancer DU145 cells. Biochem. Biophys. Res. Commun.
248, 361–367.
|
| |
| 15. |
Weinberg, R. A. (1995) The retinoblastoma protein and cell cycle control. Cell
81, 323–330.
|
| |
| 16. |
Dyson, N. (1998) The regulation of E2F by pRb-family proteins. Genes Dev.
12, 2245–2262.
|
| |
| 17. |
Dalbagni, G., Cordon-Cardo, C., Reuter, V., and Fair, W. R. (1995) Tumor suppressor gene alterations in bladder carcinoma.
Translational correlates to clinical practice. Surg. Oncol. Clin. N Am.
4, 231–240.
|
| |
| 18. |
Trudel, M., Mulligan, L., Cavenee, W., Margolese, R., Cote, J., and Gariepy, G. (1992) Retinoblastoma and p53 gene product
expression in breast carcinoma: immunohistochemical analysis and clinicopathologic correlation. Hum. Pathol.
23, 1388–1394.
|
| |
| 19. |
Tamura, G., Maesawa, C., Suzuki, Y., Kashiwaba, M., Ishida, M., Saito, K., and Satodate, R. (1994) Improved detection of loss
of heterozygosity at retinoblastoma gene locus in human breast carcinoma. Pathol. Int.
44, 34–38.
|
| |
| 20. |
Berns, E. M., de Klein, A., van Putten, W. L., van Staveren, I. L., Bootsma, A., Klijn, J. G., and Foekens, J. A. (1995) Association
between RB-1 gene alterations and factors of favourable prognosis in human breast cancer, without effect on survival. Int. J. Cancer
64, 140–145.
|
| |
| 21. |
Mori, N., Yokota, J., Akiyama, T., Sameshima, Y., Okamoto, A., Mizoguchi, H., et al. (1990) Variable mutations of the RB gene
in small-cell lung carcinoma. Oncogene
5, 1713–1717.
|
| |
| 22. |
Reissmann, P. T., Koga, H., Takahashi, R., Figlin, R. A., Holmes, E. C., Piantadosi, S., et al. (1993) Inactivation of the
retinoblastoma susceptibility gene in non-small-cell lung cancer. The Lung Cancer Study Group. Oncogene
8, 1913–1919.
|
| |
| 23. |
Linardopoulos, S., Gonos, E. S., and Spandidos, D. A. (1993) Abnormalities of retinoblastoma gene structure in human lung
tumors. Cancer Lett.
71, 67–74.
|
| |
| 24. |
Phillips, S. M., Morton, D. G., Lee, S. J., Wallace, D. M., and Neoptolemos, J. P. (1994) Loss of heterozygosity of the retinoblastoma
and adenomatous polyposis susceptibility gene loci and in chromosomes 10p, 10q and 16q in human prostate cancer. Br. J. Urol.
73, 390–395.
|
| |
| 25. |
Phillips, S. M., Barton, C. M., Lee, S. J., Morton, D. G., Wallace, D. M., Lemoine, N. R., and Neoptolemos, J. P. (1994) Loss
of the retinoblastoma susceptibility gene (RB1) is a frequent and early event in prostatic tumorigenesis. Br. J. Cancer
70, 1252–1257.
|
| |
| 26. |
Melamed, J., Einhorn, J. M., and Ittmann, M. M. (1997) Allelic loss on chromosome 13q in human prostate carcinoma. Clin. Cancer Res.
3, 1867–1872.
|
| |
| 27. |
Kubota, Y., Fujinami, K., Uemura, H., Dobashi, Y., Miyamoto, H., Iwasaki, Y., et al. (1995) Retinoblastoma gene mutations
in primary human prostate cancer. Prostate
27, 314–320.
|
| |
| 28. |
Ittmann, M. M. and Wieczorek, R. (1996) Alterations of the retinoblastoma gene in clinically localized, stage B prostate adenocarcinomas.
Hum. Pathol.
27, 28–34.
|
| |
| 29. |
Brooks, J. D., Bova, G. S., and Isaacs, W. B. (1995) Allelic loss of the retinoblastoma gene in primary human prostatic adenocarcinomas.
Prostate
26, 35–39.
|
| |
| 30. |
Bookstein, R. (1994) Tumor suppressor genes in prostatic oncogenesis. J. Cell. Biochem.
19(Suppl.), 217–223.
|
| |
| 31. |
Vesalainen, S. and Lipponen, P. (1995) Expression of retinoblastoma gene (Rb) protein in T12M0 prostatic adenocarcinoma. J. Cancer Res. Clin. Oncol.
121, 429–433.
|
| |
| 32. |
Geradts, J., Hu, S., Lincoln, C., Benedict, W., and Xu, H. (1994) Aberrant RB gene expression in routinely processed, archival
tumor tissues determined by three different anti-RB antibodies. Int. J. Cancer
58, 161–167.
|
| |
| 33. |
Wang, Y., Hayward, S., Donjacour, A., Young, P., Jacks, T., Sage, J., et al. (2000) Sex hormone-induced carcinogenesis in
Rb-deficient prostate tissue. Cancer Res.
60, 6008–6017.
|
| |
| 34. |
Cunha, G. R. and Donjacour, A. A. (1987) Mesenchymal-epithelial interactions: Technical considerations, in Assessment of Current Concepts and Approaches to the Study of Prostate Cancer (Coffey, D. S., Bruchovsky, N., Gardner, W. A., Resnick, M. I., and Karr, J. P., eds.), A.R. Liss, New York, pp. 273–282.
|
| |
| 35. |
Donjacour, A. A., Rosales, A., Higgins, S. J., and Cunha, G. R. (1990) Characterization of antibodies to androgen-dependent
secretory proteins of the mouse dorsolateral prostate. Endocrinology
126, 1343–1354.
|
| |
| 36. |
Cunha, G. R., Lung, B., and Kato, K. (1977) Role of the epithelial-stromal interaction during the development and expression
of ovary-independent vaginal hyperplasia. Dev. Biol.
56, 52–67.
|
| |